MahmoudRA, RoehrCC, SchmalischG. Current methods of non-invasive ventilatory support for neonates. Paediatr Respir Rev, 2011; 12(3):196–205.
2.
VerderH, RobertsonB, GreisenG, EbbesenF, AlbertsenP, LundstromK, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med, 1994; 331(16):1051–1055.
3.
StevensTP, HarringtonEW, BlennowM, SollRF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev, 2007(4):CD003063.
4.
AveryME, TooleyWH, KellerJB, HurdSS, BryanMH, CottonRB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics, 1987; 79(1):26–30.
5.
Van MarterLJ, AllredEN, PaganoM, SanockaU, ParadR, MooreM, et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics, 2000; 105(6):1194–1201.
6.
VanpeeM, Walfridsson-SchultzU, Katz-SalamonM, ZupancicJA, PursleyD, JonssonB. Resuscitation and ventilation strategies for extremely preterm infants: a comparison study between two neonatal centers in Boston and Stockholm. Acta Paediatr, 2007; 96(1):10–16; discussion 18-19.
7.
GittermannMK, FuschC, GittermannAR, RegazzoniBM, MoessingerAC. Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low birth weight infants. Eur J Pediatr, 1997; 156(5):384–388.
8.
PoetsCF, SensB. Changes in intubation rates and outcome of very low birth weight infants: a population-based study. Pediatrics, 1996; 98(1):24–27.
9.
FinerNN, CarloWA, WalshMC, RichW, GantzMG, LaptookAR, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med, 2010; 362(21):1970–1979.
10.
SandriF, PlavkaR, AncoraG, SimeoniU, StranakZ, MartinelliS, et al. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics, 2010; 125(6):e1402–1409.
11.
RoehrCC, SchmalischG, KhakbanA, ProquitteH, WauerRR. Use of continuous positive airway pressure (CPAP) in neonatal units–a survey of current preferences and practice in Germany. Eur J Med Res, 2007; 12(4):139–144.
JatanaKR, OplatekA, SteinM, PhillipsG, KangDR, ElmaraghyCA. Effects of nasal continuous positive airway pressure and cannula use in the neonatal intensive care unit setting. Arch Otolaryngol Head Neck Surg, 2010; 136(3):287–291.
14.
YongSC, ChenSJ, BooNY. Incidence of nasal trauma associated with nasal prong versus nasal mask during continuous positive airway pressure treatment in very low birthweight infants: a randomised control study. Arch Dis Child Fetal Neonatal Ed, 2005; 90(6):F480–F483.
15.
SpenceKL, MurphyD, KilianC, McGonigleR, KilaniRA. High-flow nasal cannula as a device to provide continuous positive airway pressure in infants. J Perinatol, 2007; 27(12):772–775.
16.
Quinn. Nasal cannula treatment for apnea of prematurity. PAS, 2005; 57:1248–1252.
17.
DiBlasiRM. Nasal continuous positive airway pressure (CPAP) for the respiratory care of the newborn infant. Respir Care, 2009; 54(9):1209–1235.
18.
CampbellDM, ShahPS, ShahV, KellyEN. Nasal continuous positive airway pressure from high flow cannula versus Infant Flow for Preterm infants. J Perinatol, 2006; 26(9):546–549.
19.
JasinLR, KernS, ThompsonS, WalterC, RoneJM, YohannanMD. Subcutaneous scalp emphysema, pneumo-orbitis and pneumocephalus in a neonate on high humidity high flow nasal cannula. J Perinatol, 2008; 28(11):779–781.
20.
VolskoTA, FedorK, AmadeiJ, ChatburnRL. High flow through a nasal cannula and CPAP effect in a simulated infant model. Respir Care, 2011; 56(12):1893–1900.
21.
LockeRG, WolfsonMR, ShafferTH, RubensteinSD, GreenspanJS. Inadvertent administration of positive end-distending pressure during nasal cannula flow. Pediatrics, 1993; 91(1):135–138.
22.
SreenanC, LemkeRP, Hudson-MasonA, OsiovichH. High-flow nasal cannulae in the management of apnea of prematurity: a comparison with conventional nasal continuous positive airway pressure. Pediatrics, 2001; 107(5):1081–1083.
23.
LamplandAL, PlummB, MeyersPA, WorwaCT, MammelMC. Observational study of humidified high-flow nasal cannula compared with nasal continuous positive airway pressure. J Pediatr, 2009; 154(2):177–182.
24.
WilkinsonD, AndersenC, O'DonnellCP, De PaoliAG. High flow nasal cannula for respiratory support in preterm infants. Cochrane Database Syst Rev, 2011(5):CD006405.
25.
NairGKP. Comparison of the effects of Vapotherm and nasal CPAP in respiratory distress. Pediatr Acad Soc, 2005; 57:2054.
26.
KubickaZJ, LimauroJ, DarnallRA. Heated, humidified high-flow nasal cannula therapy: yet another way to deliver continuous positive airway pressure?Pediatrics, 2008; 121(1):82–88.
27.
OvalleOGT, TroncosoC, PalaciosJ, OrtizE. High flow nasal cannula after surfactant treatment for infant respiratory distress syndrome in perterm infants 30 weeks. PAS, 2005; 57:3417–3423.
28.
ShoemakerMT, PierceMR, YoderBA, DiGeronimoRJ. High flow nasal cannula versus nasal CPAP for neonatal respiratory disease: a retrospective study. J Perinatol, 2007; 27(2):85–91.
29.
CourtneySE, PyonKH, SaslowJG, ArnoldGK, PanditPB, HabibRH. Lung recruitment and breathing pattern during variable versus continuous flow nasal continuous positive airway pressure in premature infants: an evaluation of three devices. Pediatrics, 2001; 107(2):304–308.
30.
DiBlasiRM. Neonatal noninvasive ventilation techniques: do we really need to intubate?Respir Care, 2011; 56(9):1273–1296.
